3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
7
Urinary Bladder Neoplasms
5
Glioma
5
Prostatic Neoplasms
4
Lung Neoplasms
4
Esophageal Neoplasms
4
Burkitt Lymphoma
4
Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Oropharyngeal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma
3
Astrocytoma
3
Uterine Cervical Neoplasms
2
Sarcoma, Ewing
2
Sarcoma
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Mouth Neoplasms
2
Mesothelioma, Malignant
2
Melanoma
2
Laryngeal Neoplasms
2
Gliosarcoma
2
Ganglioneuroblastoma
2
Brain Neoplasms
2
Adenocarcinoma of Lung
2
Wilms Tumor
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Triple Negative Breast Neoplasms
1
Interventions
Cyclophosphamide
4
Etoposide
2
sodium-iodide symporter
1
ruxolitinib
1
pembrolizumab
1
fludarabine phosphate
1
fludarabine
1
duvelisib
1
cemiplimab
1
X-Rays
1
Whole-Body Irradiation
1
Vincristine
1
Tacrolimus
1
Specimen Handling
1
Sirolimus
1
Prednisone
1
Photons
1
Peripheral Blood Stem Cell Transplantation
1
Nivolumab
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Immunoglobulin G
1
Doxorubicin
1
Disulfides
1
Cyclosporine
1
CTLA-4 Antigen
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoblastic Lymphadenopathy
×
Radiation
×
30 days
×
Clear all
No trials found.